Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan
Portopulmonary hypertension (PoPH) and hepatopulmonary syndrome are severe pulmonary complications associated with liver cirrhosis (LC) and portal hypertension. Three key pathways, involving endothelin, nitric oxide, and prostacyclin, have been identified in the development and progression of pulmon...
Main Authors: | Katsutoshi Tokushige, Tomomi Kogiso, Hiroto Egawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/2/562 |
Similar Items
-
Current clinical understanding and effectiveness of portopulmonary hypertension treatment
by: Yuichi Tamura, et al.
Published: (2023-04-01) -
The early outcomes of candidates with portopulmonary hypertension after liver transplantation
by: Bingsong Huang, et al.
Published: (2018-06-01) -
Portopulmonary Hypertension: From Bench to Bedside
by: Christopher Thomas, et al.
Published: (2020-11-01) -
Portopulmonary hypertension: state of the art
by: Mateo Porres-Aguilar, et al.
Published: (2008-10-01) -
Portopulmonary hypertension: Current developments and future perspectives
by: Huawei Xu, et al.
Published: (2022-03-01)